已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent

最大值 药代动力学 医学 吸入 药理学 Cmin公司 不利影响 毒物动力学 哮喘 加药 麻醉 内科学
作者
Lindsey Cass,Alison D. Murray,Amanda Davis,Kathy Woodward,Muna Albayaty,Kazuhiro Ito,Pete Strong,John Ayrton,Charlie Brindley,Jayne Prosser,John C. Murray,Eddie French,Phillip Haywood,Christopher Wallis,Garth Rapeport
出处
期刊:Pharmacology Research & Perspectives [Wiley]
卷期号:9 (1) 被引量:42
标识
DOI:10.1002/prp2.690
摘要

Abstract PC945 is a novel antifungal triazole formulated for nebulized delivery to treat lung Aspergillus infections. Pharmacokinetic and safety profiles from nonclinical studies and clinical trials in healthy subjects, and subjects with mild asthma were characterized. Toxicokinetics were assessed following daily 2‐hour inhalation for 14 days. Potential for drug‐drug interactions was evaluated using pooled human liver microsomes. Clinical safety and pharmacokinetics were assessed following (a) single inhaled doses (0.5‐10 mg), (b) 7‐day repeat doses (5 mg daily) in healthy subjects; (c) a single dose (5 mg) in subjects with mild asthma. C max occurred 4 hours (rats) or immediately (dogs) after a single dose. PC945 lung concentrations were substantially higher (>2000‐fold) than those in plasma. PC945 only inhibited CYP3A4/5 substrate metabolism (IC 50 : 1.33 µM [testosterone] and 0.085 µM [midazolam]). Geometric mean C max was 322 pg/mL (healthy subjects) and 335 pg/mL (subjects with mild asthma) 4‐5 hours (median t max ) after a single inhalation (5 mg). Following repeat, once daily inhalation (5 mg), Day 7 C max was 951 pg/mL (0.0016 µM) 45 minutes after dosing. Increases in C max and AUC 0–24h were approximately dose‐proportional (0.5‐10 mg). PC945 administration was well tolerated in both healthy subjects and subjects with mild asthma. Treatment‐emergent adverse events were mild/moderate and resolved before the study ended. No clinically significant lung function changes were observed. PC945 pharmacokinetics translated from nonclinical species to humans showed slow absorption from lungs and low systemic exposure, thereby limiting the potential for adverse side effects and drug interactions commonly seen with systemically delivered azoles.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的应助被lll采纳,获得10
1秒前
4秒前
小波发布了新的文献求助30
4秒前
浩whu完成签到,获得积分10
5秒前
七叶花开完成签到,获得积分10
6秒前
奥特曼打小人的应助被YIDAN采纳,获得20
6秒前
rin382发布了新的文献求助50
6秒前
冰魄落叶完成签到,获得积分10
7秒前
7秒前
华无剑的应助被萧雨墨采纳,获得10
7秒前
念槿完成签到,获得积分10
8秒前
健壮的含卉完成签到 ,获得积分10
9秒前
9秒前
12秒前
111完成签到,获得积分10
13秒前
打打的应助被好幸运采纳,获得10
14秒前
zhou完成签到,获得积分10
14秒前
QY发布了新的文献求助10
14秒前
LWY发布了新的文献求助10
15秒前
16秒前
夜月残阳完成签到,获得积分0
17秒前
btsforever完成签到,获得积分10
17秒前
1111完成签到,获得积分10
17秒前
18秒前
小波完成签到,获得积分20
18秒前
20秒前
粒粒完成签到,获得积分10
21秒前
ffff完成签到 ,获得积分0
23秒前
24秒前
25秒前
dzy完成签到,获得积分10
25秒前
25秒前
25秒前
先生先生你怎么了完成签到,获得积分10
26秒前
贺靖巧发布了新的文献求助10
27秒前
YIDAN完成签到,获得积分10
28秒前
刘伟完成签到,获得积分20
28秒前
光亮静槐完成签到 ,获得积分10
28秒前
29秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158391
求助须知:如何正确求助?哪些是违规求助? 9554206
关于积分的说明 21718287
捐赠科研通 7747762
什么是DOI,文献DOI怎么找? 3426964
关于科研通互助平台的介绍 2551704
邀请新用户注册赠送积分活动 2471132